Vitamin E: Potential to reduce common complications associated with venous access devices in cancer patients

Cynthia Chernecky, Denise Macklin, Katherine Nugent, Jennifer Waller

Research output: Contribution to journalArticle

1 Scopus citations


Vitamin E is known to have antiplatelet, fibrinolytic, and endotoxin properties. Focus-group discussion with cancer patients who had a venous access device (VAD) revealed that 14 percent felt taking vitamin E (400-800 IU/d orally) eliminated the problems of occlusion and inability to withdraw blood from their current VADs. This information is significant in that two of the patients had these problems with their previous VADs but not with their current VADs, although they were the same type of device. These findings suggest that use of vitamin E to reduce occlusion and inability to withdraw blood in cancer patients with VADs should be investigated further.

Original languageEnglish (US)
Pages (from-to)38-40
Number of pages3
JournalJournal of Cancer Integrative Medicine
Issue number1
Publication statusPublished - Dec 1 2005



  • Complementary medicine
  • Neoplasm
  • Nursing
  • Venous access device
  • Vitamin E

ASJC Scopus subject areas

  • Oncology
  • Complementary and alternative medicine
  • Pharmacology (medical)

Cite this